Suppr超能文献

脑胶质瘤的奇异微环境。

The strange Microenvironment of Glioblastoma.

机构信息

BRIC Inserm U1312, Université de Bordeaux, 33615 Pessac, France.

Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.

出版信息

Rev Neurol (Paris). 2023 Jun;179(5):490-501. doi: 10.1016/j.neurol.2023.03.007. Epub 2023 Mar 22.

Abstract

Glioblastoma (GB) is the most common and aggressive primary brain tumor, with poor patient survival and lack of effective therapies. Late advances trying to decipher the composition of the GB tumor microenvironment (TME) emphasized its role in tumor progression and potentialized it as a therapeutic target. Many components participate critically to tumor development and expansion such as blood vessels, immune cells or components of the nervous system. Dysmorphic tumor vasculature brings challenges to optimal delivery of cytotoxic agents currently used in clinics. Also, massive infiltration of immunosuppressive myeloid cells and limited recruitment of T cells limits the success of conventional immunotherapies. Neuronal input seems also be required for tumor expansion. In this review, we provide a comprehensive report of vascular and immune component of the GB TME and their cross talk during GB progression.

摘要

胶质母细胞瘤(GB)是最常见和侵袭性最强的原发性脑肿瘤,患者生存率低,缺乏有效治疗方法。最近的研究进展试图解析 GB 肿瘤微环境(TME)的组成,强调了其在肿瘤进展中的作用,并将其作为治疗靶点。许多成分对肿瘤的发展和扩张起着至关重要的作用,如血管、免疫细胞或神经系统的成分。畸形的肿瘤血管给目前临床上使用的细胞毒性药物的最佳输送带来了挑战。此外,大量浸润的免疫抑制性髓样细胞和 T 细胞的有限募集限制了传统免疫疗法的成功。神经元的输入似乎也是肿瘤扩张所必需的。在这篇综述中,我们全面报告了 GB TME 的血管和免疫成分及其在 GB 进展过程中的相互作用。

相似文献

1
The strange Microenvironment of Glioblastoma.
Rev Neurol (Paris). 2023 Jun;179(5):490-501. doi: 10.1016/j.neurol.2023.03.007. Epub 2023 Mar 22.
2
Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies.
Front Immunol. 2023 Feb 27;14:994698. doi: 10.3389/fimmu.2023.994698. eCollection 2023.
4
Challenges in glioblastoma research: focus on the tumor microenvironment.
Trends Cancer. 2023 Jan;9(1):9-27. doi: 10.1016/j.trecan.2022.09.005. Epub 2022 Nov 16.
5
The Interplay between Glioblastoma and Its Microenvironment.
Cells. 2021 Aug 31;10(9):2257. doi: 10.3390/cells10092257.
6
Unraveling the immunosuppressive microenvironment of glioblastoma and advancements in treatment.
Front Immunol. 2025 May 15;16:1590781. doi: 10.3389/fimmu.2025.1590781. eCollection 2025.
7
Phenotypic plasticity of myeloid cells in glioblastoma development, progression, and therapeutics.
Oncogene. 2021 Oct;40(42):6059-6070. doi: 10.1038/s41388-021-02010-1. Epub 2021 Sep 23.
8
Immunoediting Dynamics in Glioblastoma: Implications for Immunotherapy Approaches.
Cancer Control. 2024 Jan-Dec;31:10732748241290067. doi: 10.1177/10732748241290067.
9
Nanoparticle-based drug delivery systems to modulate tumor immune response for glioblastoma treatment.
Acta Biomater. 2025 Mar 1;194:38-57. doi: 10.1016/j.actbio.2025.01.050. Epub 2025 Jan 29.
10
Insights in the immunobiology of glioblastoma.
J Mol Med (Berl). 2020 Jan;98(1):1-10. doi: 10.1007/s00109-019-01835-4. Epub 2019 Oct 24.

本文引用的文献

1
Single-cell spatial immune landscapes of primary and metastatic brain tumours.
Nature. 2023 Feb;614(7948):555-563. doi: 10.1038/s41586-022-05680-3. Epub 2023 Feb 1.
2
Targeting Microglial Metabolic Rewiring Synergizes with Immune-Checkpoint Blockade Therapy for Glioblastoma.
Cancer Discov. 2023 Apr 3;13(4):974-1001. doi: 10.1158/2159-8290.CD-22-0455.
3
Challenges in glioblastoma research: focus on the tumor microenvironment.
Trends Cancer. 2023 Jan;9(1):9-27. doi: 10.1016/j.trecan.2022.09.005. Epub 2022 Nov 16.
4
NMDA receptor signaling induces the chemoresistance of temozolomide via upregulation of MGMT expression in glioblastoma cells.
J Neurooncol. 2022 Nov;160(2):375-388. doi: 10.1007/s11060-022-04154-w. Epub 2022 Oct 29.
6
Neuron-Glial Interactions in Health and Brain Cancer.
Adv Biol (Weinh). 2022 Sep;6(9):e2200122. doi: 10.1002/adbi.202200122. Epub 2022 Aug 11.
7
Glioblastoma hijacks neuronal mechanisms for brain invasion.
Cell. 2022 Aug 4;185(16):2899-2917.e31. doi: 10.1016/j.cell.2022.06.054. Epub 2022 Jul 31.
9
Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples.
Cancer Sci. 2022 Feb;113(2):756-769. doi: 10.1111/cas.15236. Epub 2021 Dec 24.
10
Roles of Neutrophils in Glioma and Brain Metastases.
Front Immunol. 2021 Aug 13;12:701383. doi: 10.3389/fimmu.2021.701383. eCollection 2021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验